Purigen Biosystems, Inc.
Pleasanton, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
BE
Barney E. Saunders,Ph.D.Chief Executive Officer
SR
Steve ReichenbachChief Financial Officer
BW
Bill W. Colston, Ph.D.Director
MC
Mira Chaurushiya, Ph.D.Director
KC
Kevin CorcoranDirector
KR
Klint Rose, Ph.D.Chief Scientific Officer
JJ
Joseph J. VictorExecutive Chairman of the Board of Directors
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$34.4MraisedApr 2021 · 16 investors · BiotechnologyRule 506(b)
▶$34.4MraisedApr 2021 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Barney E. Saunders,Ph.D.Executive Officer, Director
- Steve ReichenbachExecutive Officer
- Bill W. Colston, Ph.D.Director
- Mira Chaurushiya, Ph.D.Director
- Kevin CorcoranDirector
- Klint Rose, Ph.D.Executive Officer
- Joseph J. VictorDirector
- Offering amount
- $34.4M
- Amount sold
- $34.4M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$26.4MraisedJun 2018 · 28 investors · BiotechnologyRule 506(b)
▶$26.4MraisedJun 2018 · 28 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Barnett SaundersExecutive Officer, Director
- Joseph VictorDirector
- Mitchell MutzDirector
- Klint RoseExecutive Officer, Promoter
- Steve ReichenbachExecutive Officer
- Andrew SchwabDirector
- Juan SantiagoPromoter
- Bill W. ColstonDirector
- Offering amount
- $30.8M
- Amount sold
- $26.4M
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.